RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial.

Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial.

Add to Collection
2012 May RCTs Fist_Author_Year_PM

Full Author : ['Henry, R R', 'Murray, A V', 'Marmolejo, M H', 'Hennicken, D', 'Ptaszynska, A', 'List, J F']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2012
Cited by : Not Available

BACKGROUND: Combining metformin (XR) with dapagliflozin to initiate pharmacotherapy in patients with type 2 diabetes (T2D) and high baseline HbA1c may be advantageous. We conducted two randomised, double-blind, three-arm 24-week trials in treatment-naive .....

Keywords : ["randomised control trial", "dapagliflozin metformin xr", "type diabetes", "initial pharmacotherapy"]